Skip to content

Synthetic peptide protease inhibitor

BENZYLSULFONYLSERYLGLYCINE AMIDINOBENZAMIDE ACETATE

CAS 866428-02-6
70

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A synthetic dipeptide derivative branded as SYN-UP that inhibits urokinase and plasmin in skin cells. Claims center on barrier resilience and moisturisation, with most data coming from supplier studies.

Skin benefits

  • Synthetic peptide derivative promoted for skin resilience
  • Inhibits urokinase and plasmin in vitro
  • Supports moisturisation and barrier-related markers in cell studies
  • Selective inhibition profile reduces off-target protease effects

Known concerns

  • Independent clinical efficacy data are limited
  • Long-term safety of synthetic protease inhibitors in cosmetics is not well documented
  • Stability requires careful formulation pH and protection from hydrolysis

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find BENZYLSULFONYLSERYLGLYCINE AMIDINOBENZAMIDE ACETATE in your products.

Scan any cosmetic product with LuxSense to see if it contains BENZYLSULFONYLSERYLGLYCINE AMIDINOBENZAMIDE ACETATE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.